0033 GMT - In vitro fertilization specialist Monash IVF's profit warning today didn't surprise Ord Minnett much. Monash IVF today said it now expects an FY 2025 underlying net profit of some A$27.5 million, down from guidance of A$30.0 million-A$31.0 million given to investors in late February. Analyst Tom Godfrey said Monash IVF had signaled a subdued outlook at its 1H result and recent Medicare data have been weak. "While we expect medium-term consensus downgrades and a weaker share price today, we note that the updated FY 2025 P/E is 12x suggesting some of this had already been priced in," Ord Minnett says. Monash IVF falls 11% to A$0.76. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
May 19, 2025 20:33 ET (00:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。